“Doctor, we noticed a subtle change. Don’t know whether it is important but thought may be worth sharing”

“He used to be quite good at Ludo. Now he keeps making simple mistakes.”

For a moment, it seemed another of those over-observant caregiver observation. The patient was sitting upright answering questions very appropriately. There was no disorientation, no confusion, no asterixis, nothing to suggest anything was majorly wrong.

Yet the family was anxious and curious because of a board game, Ludo. Ludo has a familiar corner of most Indian homes at least for “Millenials”. For many Indian millennials, Ludo is an integral part of childhood school holidays, rainy afternoons, long train journeys. It simplicity and ease of learning make its appeal almost universal. I am not sure, how many of today’s generation are acquainted with it. Yet beneath its simplicity lies attention, anticipation, judgment and timing, things which we associate with complex cognitive tests in medicine and for this case in hepatology

Yet, for the common man no one would ever think of it as a cognitive test, not even remotely. Perhaps that is exactly why this story stayed with me and keeps resonating.

Through his observation, what the son was trying to imply was not that the father had forgotten the rules but he was describing something far subtler. These variations include longer pauses before a move, overlooked opportunities and wrong choices. At first, it may appear like a one-off error, but when it repeats again and again an observant caregiver observes what was yet unobserved.

The ludo- board did not change neither did the rules of the game, what changed was the “player”

What the caregiver was possibly watching was almost certainly a fascinating state of early cognitive impairment in patients with liver disease called minimal hepatic encephalopathy. At this stage, the person speaks normally, recognises family, answers question correctly but responses slow and errors start to creep in begin. It can affect driving, work, independence, and the burden is carried by the individual and the families. In some patients it signals that an episode of catastrophic confusion may lie ahead. Yet, in hepatology it remains less explored in routine practice primarily because we don’t have tools that can assess it in a short time across busy clinics.

We rightly pursue better tools for detecting this state with psychometric batteries, digital applications, neurophysiological measures because we need methods that are reproducible and scalable.

However, some simple questions should be a part of all out conversations and asking about changes in things that used to be easy is one such

Patients live with liver disease continuously. We clinicians encounter it in snapshots. Between those snapshots, families witness the earliest departures from normal.

Because the first sign of hepatic encephalopathy may not be confusion in a hospital bed. Sometimes it is a father sitting in front of a ludo board, unsure of a move he once made without thinking.

This essay is part of the series Conversations in Hepatology — reflections from real-world practice.

Dr. Akash Roy

Further Reading

Louissaint J et al. PMID 32677807

Saleh ZM et al. PMID 35791893

Nabi E et al. PMID 24362049

Bajaj JS et al. PMID 19670416

Shrestha D et al. PMID 32025162

From the Hepatology Diary

In Greek mythology, Sisyphus is condemned to roll a boulder endlessly up a hill, only to watch it descend again the moment he nears the summit. He never stops. The boulder never stays.

In hepatology, discharge day can feel like the summit.

The infection has settled. The creatinine has improved. The encephalopathy has cleared. A patient who arrived confused and critically unwell is now sitting up, talking, sometimes even smiling. Families gather their belongings. Prescriptions are written. Instructions are explained carefully. There is a quiet sense in the room that something difficult has been overcome.

But in cirrhosis, discharge is rarely the end of the story.

More often, it is the beginning of a fragile phase.

Consider a family we recently cared for,

The patient was a man in his late fifties, admitted with severe encephalopathy and infection. For several days, he remained sick, barely responding, eyes closed, breathing shallow. Gradually, with treatment, he improved. By the end of the week, he was awake, speaking clearly, joking gently with his son.

On the day of discharge, the relief in the room was palpable.

The son sat forward in his chair and listened carefully as medications were explained: lactulose doses, diuretics, when to call, and what to watch for. He folded the discharge papers with both hands and asked precise, considered questions. He had clearly been preparing for this moment.

They left hopeful.

Two weeks later, they were back.

The lactulose had been reduced at home because of troublesome diarrhea. The patient had grown drowsy again. The abdomen was swelling. The son looked exhausted when he came in. He hesitated before speaking, as though apologizing for the return.

“Doctor, we tried to follow everything exactly. I’m not sure where we went wrong.”

They hadn’t gone wrong.

The disease had simply continued.

This is the revolving door of cirrhosis

and it is more common than our discharge summaries acknowledge.

Among patients with cirrhosis, readmission rates within thirty days are substantial, rising sharply among those with multiple complications. Hepatic encephalopathy alone nearly doubles the risk of early return. These are not failures of care. They are the natural trajectory of an unstable disease meeting an underprepared transition.

What makes this transition so difficult is that it asks families to do something no hospital adequately trains them for. Managing cirrhosis at home means adjusting lactulose for diarrhea without allowing encephalopathy to creep back. It means distinguishing fatigue from early confusion. It means knowing whether increasing abdominal girth warrants a call, a visit, or quiet monitoring.

It means doing all of this while managing the financial pressure of medications, the disruption to employment, and the quiet grief of watching someone they love remain so fragile.

The burden on caregivers in cirrhosis is substantial across domains, affecting quality of life, mental health, and physical wellbeing and it increases steadily as the disease progresses.

Yet it is rarely assessed at the point of discharge, and almost never addressed directly in the conversation that sends families home.

The son who brought his father back two weeks later had done everything correctly.

He had noted the diarrhoea and made a sensible adjustment. He had watched for the drowsiness and recognised it early. He had returned to the hospital at the right moment.

None of this was failure.

But it felt like a failure to him. That is the cost of inadequate preparation , not just clinical relapse, but the psychological weight that families carry when they believe a return to hospital means they fell short.

We send patients home with prescriptions. We explain the medications. But we do not always say the harder thing: that this disease will push back, that fluctuations are expected, that returning to the hospital is not a defeat.

That silence is something we can change.

The literature has begun to map what helps.

Hospital navigators, who offer structured patient and caregiver education and early telemedicine follow-up, have each been shown to ease the transition from hospital to home. A clinic review within the first week, when uncertainty is highest and families are most likely to misinterpret symptoms, may matter more than any adjustment made at the time of discharge.

But even these interventions work best when paired with something simpler.

A clear list of warning signs, written in plain language rather than dense clinical summaries. A phone number to call before the next crisis. An explicit acknowledgment, said aloud at the bedside, that managing cirrhosis at home is genuinely difficult and that needing help is not the same as having failed.

Caregiver exhaustion is a clinical signal. It belongs in our assessment as much as the bilirubin trend. When families are overwhelmed, medications are missed, symptoms are misread, and the boulder rolls back faster.

Recognizing this is not beyond our capacity. It requires time, attention, and a willingness to extend the discharge conversation beyond the prescription pad.

In hepatology, discharge often feels like success.

But it is often a fragile one.

Behind the improved numbers lies a complicated reality of medications, vigilance, uncertainty, and quiet family effort. The real work of managing cirrhosis may begin not on the ward, but in the weeks after patients return home, in kitchens and corridors, and at three in the morning when a family is trying to decide whether to call.

Our patients carry the boulder.

But unlike Sisyphus, they are not condemned by myth.

They are limited by the systems we build around them.

And that is something we can change

This essay is part of the series Conversations in Hepatology — reflections from real-world practice.

Dr. Akash Roy

Further Reading

Tapper EB et al. — Thirty-day readmission in cirrhosis: rates, reasons, and the outsized role of hepatic encephalopathy. PubMed

Frenette C et al. Closing the revolving door: transition of care strategies after hepatic encephalopathy hospitalisation. PubMed

Bajaj JS et al. — The multidimensional burden of cirrhosis and encephalopathy on patients and caregivers. PubMed

Ufere NN et al. — Burdensome transitions of care for patients with end-stage liver disease and their caregivers. PubMed

Low JTS et al. — What patients and families need but rarely receive: a systematic review of palliative and supportive care in cirrhosis. PubMed

Yet in practice, there are moments when the numbers explain less than we expect.

A patient lies in the ward, visibly exhausted. Ascites has returned despite diuretics. The bilirubin has climbed again. Creatinine, once stable, begins to drift upward. Infection may have been treated, albumin administered, medications adjusted. Yet the clinical course feels uneasy — less predictable than the algorithms suggest.

And so the dilemma begins.

Medicine trains us to think in interventions: what can be done next, what can be optimized, what procedure might help. But with advanced liver disease, the path forward is rarely straightforward. Some patients improve unexpectedly. Others deteriorate rapidly despite every effort.

The challenge, however, is not only clinical.

It is conversational.

Families rarely ask about MELD scores.

They ask questions that are harder to answer.

“Doctor, will he recover?” “How serious is this?” “What should we prepare for?”

These questions arrive at the bedside long before certainty does.

Let us consider one such patient

A thirty-five year old man. Daily drinker. The family’s sole earner. He came in with alcohol-related hepatitis — jaundice climbing, blood pressure beginning to fall, urine output quietly diminishing. Then somnolence. Then the ventilator. Three days passed. Then four. The numbers moved only in one direction. There was no transplant pathway. The bills were accumulating. His family sat outside, wanting their father, their husband, their breadwinner back. The doctors knew, with the particular certainty that experience confers, where this was going.

No score needed to confirm it.

The hardest conversation here is never about the individual lab values.

Modern hepatology has become increasingly sophisticated in predicting outcomes. Prognostic scores and classifications help frame risk and guide transplant prioritisation. Yet even the best models remain imperfect at the bedside. Two patients with similar laboratory values may follow very different trajectories. Frailty, infections, delayed presentation, and social circumstances shape outcomes in ways that no score fully captures.

In these moments, the physician must navigate uncertainty while still offering guidance.

The literature has begun to recognise that patients with advanced liver disease carry a heavy burden of symptoms, uncertainty, and distress. Yet conversations about goals of care and supportive approaches are still introduced late in many patients’ journeys. Even among hospitalised individuals with severe liver failure, palliative care involvement remains inconsistent.

Beyond medical uncertainty lies another reality — one that is less visible in clinical discussions: the burden carried by families.

For those who recover from severe liver illness, the journey rarely ends at discharge. Recurrent hospital visits, prolonged weakness, medication costs, and lost income can reshape lives over months and years. Financial toxicity is increasingly recognised as a consequence of serious illness, and chronic liver disease is no exception. Families frequently assume the role of caregivers — managing medications, monitoring encephalopathy, coordinating hospital visits, and navigating complex and often indifferent systems.

These realities inevitably shape the conversations physicians have with families.

Discussing prognosis in liver disease is rarely a single moment. It unfolds gradually as the clinical course evolves. A cautious explanation one day may need revision the next. Families listen closely, searching for signs of improvement or decline, while clinicians attempt to communicate probabilities rather than certainties.

Communication itself becomes a clinical skill.

The challenge is not simply explaining laboratory values or treatment options. It is conveying uncertainty without eroding trust. It is acknowledging the limits of medicine while still providing guidance. It is knowing when to speak and, sometimes, when to simply be present.

In these moments, hepatology becomes less about numbers and more about judgment.

Guidelines remain essential. Evidence remains the foundation of modern medicine. Yet at the bedside, decisions are shaped by experience, intuition, and careful listening — to patients, to families, and to the subtle signals of deterioration that no score can fully quantify.

This is why real-world practice rarely resembles the clean pathways described in textbooks.

Patients arrive late. Complications overlap. Social and financial pressures influence decisions. Families struggle to process complex information delivered during moments of acute distress. The physician navigates all of this while continuing to make clinical decisions under uncertainty.

These are the conversations that define hepatology.

They occur in ward corridors, beside hospital beds, and in quiet rooms where families gather to understand what the future might hold.

They remind us that medicine is not only a science of data — it is a practice shaped by human experience.

In hepatology, the most difficult questions are rarely about the liver alone.

They are about what lies ahead — for the patient, for the family, and for the life that continues after illness.

This essay opens the series Conversations in Hepatology — reflections from real-world practice.

Dr. Akash Roy

Further Reading

Patidar KR et al. — Severe alcohol-associated hepatitis in the ICU: younger patients, higher MELD, worse survival. PubMed

Rogal SS et al. — AASLD guidance on palliative care and goals-of-care in decompensated cirrhosis. PubMed

Low JTS et al. — Patients and families understand less about advanced liver disease than clinicians assume. PubMed

Ufere NN et al. — Financial distress in chronic liver disease is common, underrecognised, and worsens outcomes. PubMed

Arora A et al. — INASL guidance on futility in liver transplantation in the Indian context. PubMed

EASL CPG. — Futility of intensive care and triage decisions in acute-on-chronic liver failure. PubMed